CRISPR Technology Market Report 2026

CRISPR Technology Market Overview

• CRISPR Technology market size has reached to $2.53 billion in 2025 • Expected to grow to $6.92 billion in 2030 at a compound annual growth rate (CAGR) of 22.2% • Growth Driver: The Impact Of Increasing Clinical Trials On The Growth Of The CRISPR Technology Market • Market Trend: Breakthroughs in CRISPR Technology Enhancing Gene Editing Precision for Diverse Applications • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under CRISPR Technology Market?

CRISPR technology refers to a revolutionary gene-editing tool that enables precise modifications of DNA in living organisms. It is used to alter genes for various applications, including disease treatment, agricultural improvements, and biological research. The main types of products in CRISPR technology are design tools, plasmid, and vector, CAS9 and G-RNA and delivery system products. CRISPR-Cas9 is a groundbreaking technology that allows geneticists and medical researchers to edit portions of the genome by removing, inserting, or changing DNA sequences. The different applications include genome editing or genetic engineering, genetically modified organisms, agricultural biotechnology, others and are used by several sectors such as industrial biotech, biological research, agricultural research, therapeutics, and drug discovery.

What Is The CRISPR Technology Market Growth Forecast?

The crispr technology market size is expected to see exponential growth in the next few years. It will grow to $6.92 billion in 2030 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to clinical translation of gene editing therapies, growth of precision medicine, expansion of gene-edited crops, advancements in delivery technologies, strengthening regulatory frameworks. Major trends in the forecast period include expansion of therapeutic gene editing applications, growing adoption in agricultural biotechnology, increased use in functional genomics research, rising demand for advanced delivery systems, focus on precision and off-target reduction.

What Is The Driver Of The CRISPR Technology Market?

The increasing number of ongoing clinical trials is expected to propel the growth of the CRISPR technology market going forward. A clinical trial is a research study that tests a new medical treatment, device, or approaches in people to determine if a new intervention is safe and effective. CRISPR technology is a powerful gene editing tool used in several clinical trials to treat various diseases, including cancer, blood disorders, inherited eye diseases, and infectious diseases. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, highlighted that the number of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, the increasing number of ongoing clinical trials drives the growth of the CRISPR technology industry.

Key Players In The Global CRISPR Technology Market

Major companies operating in the crispr technology market are Crispr Therapeutics, Thermo Fisher Scientific, Intellia Therapeutics, Horizon Discovery, Synthego Corporation, Integrated Dna Technology (Danaher), Editas Medicine, GenScript, Agilent Technologies, New England Biolabs, CSIR-Institute of Genomics & Integrative Biology (IGIB), Strand Life Sciences Pvt. Ltd., Bio Palette Co. Ltd., CSL Limited, C4U Co. Ltd., BGI Group, Churchi Genome Engineering and Therapeutic Research Center., Beam Therapeutics Inc., Eurofins Genomics India, Setsurotech Co. Ltd., Merck Japan, Institut Pasteur, CureVac, Cellectis, BiovelocITA S.r.l., Evotec A.G., SNIPR Biome, Oxford Genetics, ERS Genomics, Alia Therapeutics, Solvo, BioTalentum, Rosneft, BIOCAD, BioVendor, Research & Diagnostic Products, Contipro, Lonza Biotec, Sotio, Selvita, BioVentures Institute Ltd, Sigma-Aldrich, Poseida Therapeutics, NanoCellect Biomedical, Sherlock Biosciences, Repare Therapeutics, Inscripta Inc., Santa Cruz Biotechnology, Caribou Biosciences Inc., Egenesis Inc., Homology Medicines, System Biosciences, Takara Bio USA Inc., Inari Agriculture Inc., Precision BioSciences, Cell Microsystems Inc., GeneCopoeia Inc., Merck KGaA, Origene Technologies Inc., Pluristem Therapeutics Inc.

Global CRISPR Technology Market Trends and Insights

Major companies in the CRISPR technology market are focused on developing advanced gene editing tools to enhance precision in genomic modifications for applications in medicine, agriculture, and biotechnology. Gene-editing tools are technologies that enable precise modifications to an organism's DNA, allowing for the addition, deletion, or alteration of genetic material. These tools, such as CRISPR-Cas9, facilitate targeted changes to genes, advancing research in genetics, medicine, and biotechnology. For instance, in May 2024, Profluent Bio Inc., an Ireland-based AI-first protein design company, launched OpenCRISPR-1 to Edit the Human Genome. It offers significant benefits in the field of gene editing by achieving a 95% reduction in off-target effects, which enhances the precision of genetic modifications compared to traditional CRISPR systems. Additionally, its open-source nature allows researchers worldwide to customize and optimize the tool for various applications, promoting ethical usage and accelerating the development of new therapies for genetic disorders.

What Are Latest Mergers And Acquisitions In The CRISPR Technology Market?

In February 2023, Sherlock Biosciences, a US-based health company that develops diagnostic tools to make health information more accessible, accurate, and affordable, acquired Sense Biodetection for an undisclosed amount. With this acquisition, Sherlock Biosciences aims to accelerate the development of user-friendly, CRISPR-based diagnostic tools that make accurate health testing accessible to consumers. Sense Biodetection Limited is a UK-based molecular diagnostics company that specializes in rapid, point-of-care diagnostic solutions.

What Defines the CRISPR Technology Market?

The CRISPR technology market includes revenue earned by CRISPR Screening Libraries, CRISPR Positive Controls, CRISPR Negative Controls, and Gene-specific Knockout Kits. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the CRISPR Technology Market Report 2026?

The crispr technology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the crispr technology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.